Spleen angiosarcoma
diseaseOn this page
Also known as angiosarcoma (disease) of spleenangiosarcoma of spleenangiosarcoma of the spleenhemangiosarcoma of spleenhemangiosarcoma of the spleenspleen angiosarcoma (disease)splenic angiosarcomasplenic hemangiosarcoma
Summary
Spleen angiosarcoma (MONDO:0002376) is a disease. A subtype of spleen cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | spleen angiosarcoma |
| Mondo ID | MONDO:0002376 |
| DOID | DOID:265 |
| NCIT | C4564 |
| SNOMED CT | 187821001 |
| UMLS | C0346424 |
| MedGen | 83426 |
| GARD | 0023126 |
| Anatomy (UBERON) | UBERON:0002106 |
| Is cancer (heuristic) | no |
Also known as: angiosarcoma (disease) of spleen · angiosarcoma of spleen · angiosarcoma of the spleen · hemangiosarcoma of spleen · hemangiosarcoma of the spleen · spleen angiosarcoma (disease) · splenic angiosarcoma · splenic hemangiosarcoma
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › immune system cancer › lymphatic system cancer › spleen cancer › spleen angiosarcoma
Related subtypes (4): splenic manifestation of leukemia, gastric mucosa-associated lymphoid tissue lymphoma, small intestinal mucosa-associated lymphoid tissue lymphoma, tonsillar lymphoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.